Aurobindo Pharma closing in on .5b Zentiva buyout

Aurobindo Pharma closing in on $5.5b Zentiva buyout

Mumbai: Aurobindo Pharma has emerged as the frontrunner to acquire Prague-based generic drugmaker Zentiva for $5-5.5 billion (Rs 43,500-47,900 crore) from Advent International, said several people aware of the matter, underscoring the growing consolidation of pharmaceutical assets in Europe. If successful, this will be the largest-ever acquisition by an Indian pharma company, both at home…

Read More